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Abstract
While there has been significant progress in determining the transcriptional cascade involved in terminal adipocyte
differentiation, less is known about early events leading to lineage commitment and cell fate choice. It has been recently
discovered that zinc finger protein 423 (Zfp423) is an early actor in adipose determination. Here, we show that a close
paralog of Zfp423, Zfp521, acts as a key regulator of adipose commitment and differentiation in vitro and in vivo. Zfp521
exerts its actions by binding to early B cell factor 1 (Ebf1), a transcription factor required for the generation of adipocyte
progenitors, and inhibiting the expression of Zfp423. Overexpression of Zfp521 in cells greatly inhibits adipogenic potential,
whereas RNAi-mediated knock-down or genetic ablation of Zfp521 enhances differentiation. In addition, Zfp521
2/2
embryos exhibit increased mass of interscapular brown adipose tissue and subcutaneous white adipocytes, a cell
autonomous effect. Finally, Ebf1 participates in a negative feedback loop to repress Zfp521 as differentiation proceeds.
Because Zfp521 is known to promote bone development, our results suggest that it acts as a critical switch in the
commitment decision between the adipogenic and osteogenic lineages.
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Introduction
Mesenchymal stem cells can differentiate into a variety of
lineages,includingfat, bone,muscle,and cartilage[1]. Inparticular,
there has beenemphasisplacedon understandinghowcommitment
is determined in cells that could become bone or fat, as these
processes are considered relevant to the twin epidemics of obesity
and osteoporosis. Numerous studies have shown an inverse
relationship between bone and fat development, such that marrow
adiposity increases with age [2], while the clinical use of
proadipogenic PPARc agonists increases fracture risk [3–6]. At
the molecular level, reciprocal regulation between adipogenic and
osteogenic regulatory factors has been noted. Activation of PPARc
inhibits the activity of the osteoblastogenic master regulator Runx2
[7], while the osteogenic transcription factor Msx2 inhibits PPARc
and C/EBPa [8,9]. Other transcriptional components that exert
opposing effects on adipogenesis and osteogenesis include Taz [10],
DfosB [11], Rb [12], and Maf [13]. Together, these studies suggest
that there is a molecular balance between these two lineages.
Late events in adipocyte terminal differentiation have been well-
studied, and a transcriptional cascade has been identified that
includes PPARc, C/EBPa, and a burgeoning network of other
factors [14]. Our understanding of early events in adipogenesis,
however, is relatively underdeveloped. Notably, Zfp423 and
Tcf7L1 have been recently proposed to facilitate early determi-
nation events in adipogenesis [15–17]. Zfp423 is a large and
interesting molecule, containing 30 C2H2 Kru ¨ppel-like zinc
fingers. In addition to promoting adipose lineage determination,
Zfp423 also regulates development in the brain [18,19], exerting
its actions in part through physical interactions with various
binding partners, including RAR/RXR [20], Smads [15], and
early B cell factor 1 (Ebf1) [21,22]. Originally described as a
regulator of olfactory epithelial differentiation [23] and B-cell
lymphopoiesis [24], Ebf1 is proadipogenic [25,26] and also
appears to operate early in the commitment phase of differenti-
ation [27]. Thus, Ebf1
2/2 mice are not only lipodystrophic but
actually lack adipocyte progenitor cells [27,28].
Zfp521, also known as Evi-3 in the mouse (ZNF521/EHZF in
the human), is the only close paralog of Zfp423 in the mammalian
genome; both factors contain he same array of 30 C2H2 Kru ¨ppel-
like zinc fingers. Zfp521 is enriched in primitive cell types, such as
neural precursor cells, immature olfactory neurons, and CD34
+
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also a critical regulator of osteoblast formation in vivo [32,33], and
in chondrocytes, Zfp521 acts downstream of parathyroid hor-
mone-related peptide to inhibit Runx2 and increase growth plate
thickness [32]. The tissue distributions of Ebf1 and Zfp521 are
similar [31,34], and Zfp521 opposes Ebf1 activity in B-cell
development [35,36] and olfactory epithelium development [37].
Taken together, Zfp521 appeared to us to be an excellent
candidate for a factor regulating critical early events in adipogen-
esis.
Here, we identify such a role for Zfp521 as a negative regulator
of adipose tissue development. Expression of Zfp521 is reduced
during adipogenesis, and gain- and loss-of function studies in vitro
and in vivo demonstrate that Zfp521 is a repressor of adipogenesis.
We identify Zfp423 as a critical downstream target of Zfp521, and
we show that the ability of Zfp521 to repress Zfp423 and
adipogenesis depends upon its ability to bind to and inhibit the
transcriptional activity of the proadipogenic factor Ebf1. Finally,
we establish a negative feedback loop in which Ebf1 binds to an
intronic enhancer of the Zfp521 gene and represses its expression.
Our data establish that Zfp521 acts early in adipogenesis to
negatively regulate differentiation, at least in part through direct
inhibition of Ebf1 and subsequent repression of Zfp423 expression.
Results
Zfp521 Inhibits Adipogenesis In Vitro
We noted that expression of Zfp521 declines during adipogen-
esis in multipotent C3H10T1/2 cells (Figure 1A). This pattern was
also seen during differentiation of 3T3-L1, 3T3-F442A, and
human adipose stromal cells (ASCs) into adipocytes (Figures S1A–
S1C), and protein levels declined as well (Figure 1B). Consistent
with the in vitro data, Zfp521 levels are higher in the stromal-
vascular fraction (which contains preadipocytes) than in the
adipocyte fraction of fat pads taken from wild-type mice
(Figure 1C). To prove that Zfp521 is expressed in bona fide
preadipocytes, we isolated green fluorescent protein (GFP)+ cells
from the stromal-vascular fraction of transgenic mice bearing GFP
inserted into the Zfp423 start site; such cells have been shown to
represent the preadipocyte population of the stromal-vascular
fraction (SVF) [16]. As expected, GFP+ cells had significantly
higher Zfp521 expression than GFP2 cells from the same fat pads
(Figure 1C). On the basis of its expression pattern, we predicted
that Zfp521 would inhibit adipogenesis. This was indeed the case,
as overexpression of Zfp521 in C3H10T1/2 (Figure 1D, 1E), 3T3-
L1 cells (Figure S1D, S1E), and mouse embryonic fibroblasts
(MEFs) (Figure S2F, S2G) blocked lipid accumulation and
adipogenic gene expression, while shRNA-mediated knockdown
of Zfp521 (sh521) had the opposite effect (Figures 1F, 1G, S1F,
and S1G). This was not an off-target effect of the Zfp521 shRNA,
as Zfp521
2/2 primary MEFs and stromal-vascular cells taken from
the fat pads of Zfp521
+/2 mice also showed enhanced adipogenic
potential compared to wild-type cells (Figures S1H–S1K). This
effect was also true in human ASCs, indicating that the role of
Zfp521 as an antiadipogenic factor is not confined to the rodent
lineage (Figure S1L, S1M). Furthermore, overexpression of
Zfp521 in C3H10T1/2 and MEFs pushed cells towards an
osteoblastic fate, demonstrated by staining and gene expression
patterns (Figure S2A–S2D). Thus, the combined data from gain-
and loss-of-function studies consistently demonstrate that Zfp521
acts as a repressor of adipogenesis and a promoter of osteogenesis
in multiple systems in vitro.
Reducing Zfp521 Enhances Adipogenesis In Vivo
We next sought to determine whether our findings could be
replicated in vivo. Unfortunately, Zfp521
2/2 mice die shortly after
birth, so we focused our analysis on the development of white and
brown adipocytes in late stage embryos (embryonic day 18.5).
Zfp521
2/2 embryos display an increased number of differentiating
white adipocytes in the subdermal connective tissue when detected
by the concordance of FABP4 immunostaining and cytoplasmic
lipid droplets (Figures 2A, 2B). Remarkably, Zfp521
2/2 embryos
display significantly enlarged brown adipose depots relative to
wild-type littermates when assessed by histology (Figure 2C) and
tissue weight (Figure 2D) without major gene expression changes
(Figure S3A); liver weight, by contrast, is not different between the
two genotypes. Together, these observations suggest that Zfp521
negatively regulates the embryonic development of white and
brown adipose tissue.
To determine if these effects were cell autonomous, we took
advantage of the ability of 3T3-F442A cells to develop into fat
pads when implanted into nude mice [38] to create a competition-
based assay for adipogenic potential in vivo. 3T3-F442A cells were
transduced with retrovirus expressing either sh521 or a scrambled
shRNA control (shScr), and the two cell types were then mixed
together at a 1:1 ratio prior to implantation in nude mice; we
reasoned that the hairpin conferring greater adipogenic potential
should be overrepresented in the resulting fat pad. Hematoxylin–
eosin (HE) staining and protein expression of C/EBPa and FABP4
from implants show that injected cells developed into adipose
tissue (Figures S3B, S3C). The relative amount of each hairpin was
determined using quantitative PCR (Q-PCR) to measure hairpin-
specific sequences normalized to hairpin-independent sequences.
By first determining the relative abundance of each hairpin in
mixtures of input cells at fixed ratios, we established a baseline by
which we could normalize results from the harvested tissue (Figure
S3D). This analysis revealed that sh521 cells accounted for
approximately 78% of the adipocytes in the fat pads, significantly
greater than the 50% expected if Zfp521 knockdown had no effect
(Figure 2E). We thus established that the effect of Zfp521 on
adipogenesis is cell autonomous.
Zfp521 Is an Early Regulator of Adipogenesis
We next sought to determine whether Zfp521 was acting early,
late,or perhapsat multiple time points inthe differentiation process.
As shown previously, Zfp521 sharply repressed lipid accumulation
Author Summary
Adipocytes or fat cells derive from the same stem cells that
give rise to bone, cartilage, and muscle. Understanding the
switch between bone and fat is of particular medical
importance, with implications for diseases like osteoporosis
and obesity. Here, we have identified a transcription factor
called Zfp521 which is integral to adipogenesis. Prior work
has shown that Zfp521 is important in bone formation.
Using a variety of overexpression and knockout models, we
show that Zfp521 blocks fat cell formation in cultured cells
and in living animals. Furthermore, we show that Zfp521
performs this function by binding to another transcription
factor, early B cell factor 1 (Ebf1), and repressing the
expression of Zfp423, a transcriptional regulator of pre-
adipocyte determination. Finally, we show that Zfp521 is
itself repressed by Ebf1, providing a mechanism that turns
the levels of this antiadipogenic protein off once the
decision to undergo fat cell development has been made.
We postulate that Zfp521 regulates one of the earliest
events in the lineage switch between bone and fat.
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effect was largely reversed by adding PPARc or C/EBPa (Figures
S3E, S3F). We also assessed whether knocking down Zfp521 in cells
lacking PPARc would allow adipogenesis to proceed. While viral
delivery of shZfp521 promoted adipogenesis in cells that contain
PPARc (Pparc
+/2), cells lacking PPARc entirely (Pparc
2/2) did not
undergo differentiation (Figures S3G–S3K). Taken together, these
data suggest that Zfp521 acts prior to PPARc in the differentiation
cascade.
Zfp521 Inhibits Preadipocyte Commitment Factor Zfp423
Because Zfp521 is a transcriptional regulator, we sought to identify
downstream targets in preadipocytes using Affymetrix arrays. We
performed these experiments in both gain-of-function and loss-of-
function contexts to enhance our ability to identify bona fide targets of
Zfp521, focusing on genes that showed coordinate regulation between
Zfp521 overexpression and knockdown. There were 631 genes whose
expression fell below 70% of baseline when Zfp521 was targeted by
RNAi, while surprisingly few targets (five) increased by more than 1.5-
fold when Zfp521 was overexpressed (Figure S4A). A total of three
genes (Dusp1, Fos,a n dSerpina3m) showed coordinate regulation,
demonstrating that they are bona fide positive targets of Zfp521.
Conversely, there were 347 genes whose expression increased upon
treatment with sh521, and 114 that were diminished by Zfp521
overexpression (Figure 3A); only seven of these genes were coordinately
regulated. These seven genes include poorly annotated transcripts of
uncertain function (e.g. 3830408D07RIK), some of which reside in a
1.3-MB cluster on the X chromosome (OTT/LOC434863/
LOC434864/LOC434865/LOC666184/LOC660260). Most of the
others are also relatively unstudied, and include a sphingosine-1-
phosphate receptor (Edg3), a per hexamer repeat gene (Phxr5), and the
cell structural and matrix genes synemin (Dmn) and fibromodulin
(Fmod). The final gene on the list of those coordinately regulated by
Zfp521 was, however, of particular interest to us: Zfp423, the most
highly paralogous gene to Zfp521 and a factor recently shown to
promote adipose linage commitment [15]. Q-PCR analysis in
preadipocytes confirmed that Zfp521 exerts strong repressive effects
on Zfp423 expression (Figure 3B), and that reducing Zfp521 has the
converse effect (Figure 3C).
Zfp521 Inhibits Ebf1 Transcriptional Activity through
Physical Interaction
Zfp521 interacts with Ebf1 in the context of hematopoiesis [36].
Because we have previously shown that Ebf1 is a strong inducer of
Figure 1. Zfp521 is a suppressor of adipogenesis in vitro. (A)
C3H10T1/2 cells were differentiated and RNA isolated at the indicated
time points. Gene expression of Zfp521 and Pparg was measured by Q-
PCR and normalized to cyclophilin. Data shown as mean of three
biological replicates. (B) Protein lysates isolated during 3T3-L1
adipogenesis were subjected to western blotting with anti-Zfp521
antibody. (C, left) Zfp521 mRNA expression was measured in
fractionated subcutaneous and epididymal fat tissue taken from wild-
type mice (SV, stromal-vascular fraction; AD, adipocytes). (C, right) SV of
epididymal fat tissue from Zfp423
GFP transgenic mice was sorted with
GFP antibody and plated. After washing away floating cells, Zfp521
mRNA expression was measured in GFP2 and GFP+ cells. (D–G)
C3H10T1/2 cells were retrovirally transduced with Zfp521, empty
vector, shRNA specific forZfp521 (sh521), or a scrambled hairpin (Scr).
Overexpression and knock-down were confirmed by immunoblotting of
Zfp521 prior to differentiation in the boxed insert. Cells were
differentiated with DMI or DMI plus rosiglitazone (DMIR) and stained
with oil red-O (D, F) and adipocyte markers were determined by Q-PCR
(E, G) on day 8. Data presented as mean 6 SD, n=3,*p,0.05.
doi:10.1371/journal.pbio.1001433.g001
Figure 2. Reduction of Zfp521 enhances adipogenic potential
in vivo. (A) Sections of the subcutaneous region of e18.5 Zfp521
+/+
and Zfp521
2/2 embryos were stained with anti-FABP4 (red) and DAPI
(blue). The magnified section shows representative FABP4
+, lipid-filled
cells. (B) ,20–25 images per embryo were used to quantify the
number of lipid-filled and FABP4-positive adipocytes. Zfp521
+/+, n=4
embryos; Zfp521
2/2, n=6 embryos; *p,0.05. (C, D) Representative
histology (HE staining) of the interscapular BAT region from Zfp521
+/+
and Zfp521
2/2 e18.5 embryos (red arrowhead, interscapular BAT;
white arrow, skeletal muscle) (C) and BAT and liver weight relative to
total body weight (D). Data presented as mean 6 SD, Zfp521
+/+ (n=9);
Zfp521
2/2 (n=15), *p,0.05. (E) shZfp521 and scrambled hairpin
(shScr) expressing F442A cells were mixed and injected into nude
mice. Percentage contribution of shScr and sh521-expressing cells in
fat pads determined using specific Q-PCR (see text for details). Data
presented as mean 6 SD, n=11, *p,0.05.
doi:10.1371/journal.pbio.1001433.g002
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Ebf1 in preadipocytes, and whether this might underlie the anti-
adipogenic actions of Zfp521. Zfp521 physically interacts with co-
transfected Ebf1 in HeLa cells (Figure S4B), and this effect is also
seen using co-immunoprecipitation of native proteins in 3T3-L1
preadipocytes (Figure 4A). Zfp521 inhibits the transcriptional
activity of Ebf1 on the mouse mb-1 promoter region as well as the
promoters of Sncg (a highly Ebf1-responsive gene in adipocytes;
MJG and EDR, unpublished data) and Cebpa (Figure 4B–4D).
Further, Zfp521 is recruited to the same location as Ebf1 on the
Cebpa promoter [25] (Figure 4E). Ebf1 shows a slight ability to
promote differentiation in immortalized Zfp521
+/+ MEFs, an effect
dramatically enhanced in Zfp521
2/2 cells. Reintroduction of
Zfp521 reversed the effect in both genotypes (Figure 4F, 4G).
Zfp423 interacts with Ebf1 via its most C-terminal cluster of zinc
fingers [32]. We therefore tested this in Zfp521 using a mutant
allele missing zinc fingers 27–30 (Zfp521DZF27-30) (Figure S4D).
Zfp521DZF27-30 is less able to interact with Ebf1 than wild-type
Zfp521 in a co-immunoprecipitation assay (Figure S4E), and
exhibits reduced ability to suppress Ebf1 transcriptional activity
(Figure S4F). We also focused on the first 13 amino acids of
Zfp521 (Figure S4D), which contain a motif conserved among
other zinc finger transcriptional repressors like Fog-1 and Fog-2
that is required for Zfp521 to regulate erythropoiesis through
physical interaction with GATA-1 and the nuclear remodeling and
histone deacteylation (NuRD) complex [32]. In contrast to the
DZF27-30 mutant, Zfp521D13aa is almost fully able to suppress
Ebf1 activity on the Cebpa promoter (Figure S4F). Consistent with
these results, wild-type Zfp521 and Zfp521D13aa, but not
Zfp521DZF27-30, could fully repress adipogenesis in C3H10T1/
2 cells (Figure 4H, 4I). Importantly, Ebf1 induces Zfp423
expression, an effect which can be blocked by WT Zfp521, but
not Zfp521DZF27-30 (Figures 4J, 4K). This indicates that the
effect of Zfp521 on Zfp423 expression is mediated via the
interaction with Ebf1.
Given that Zfp521 and Zfp423 contain highly homologous Ebf1
binding domains, we speculated that Zfp521 might compete with
Zfp423 for binding to Ebf1. Using coimmunoprecipitation assays,
we confirmed that both Zfp521 and Zfp423 bind readily to Ebf1,
but to our surprise, the addition of either Zfp521 or Zfp423
enhances binding of the other protein (Figure S5A), an effect seen
even in the presence of a large excess of either protein. This
suggested to us that Zfp521 and Zfp423 might heterodimerize,
and this is indeed the case, even in the absence of Ebf1 (Figures
S5B, S5C). The full significance of this interaction is still unclear,
but it suggests that Ebf1 binds Zfp521 and Zfp423 simultaneously,
with the heterodimer showing enhanced affinity for Ebf1 relative
to Zfp521 or Zfp423 monomers or homodimers. We postulate that
the downstream effect of Zfp binding to Ebf1 depends upon the
content of Zfp521 in the dimer. Consistent with this idea, the
Zfp521/Zfp423 ratio falls dramatically almost immediately upon
the induction of differentiation, and becomes even more lopsided
in favor of Zfp423 as adipogenesis proceeds (Figure S6).
Zfp521 and Ebf1 Negatively Regulate the Expression
Each Other during Adipogenesis
In order to determine why Zfp521 levels decline during
adipogenesis, we turned to our previously published genome-wide
chromatin state maps generated from 3T3-L1 cells [39], which
demonstrated a single strong H3K4me3 peak at the Zfp521
promoter that diminishes as differentiation proceeds (Figure 5A).
H3K36me3, a mark of transcriptional elongation, also diminishes
in a differentiation-dependent manner. Non-promoter H3K27
acetylation (H3K27Ac), which marks active regulatory sites,
revealed a single cluster of peaks in the second intron of the
Zfp521 gene, which was dramatically reduced in mature
adipocytes, suggesting negative regulation at this locus. We have
recently profiled Ebf1 binding sites in mature L1 adipocytes and
have found a cluster of peaks that precisely coincide with these
enhancer sites (Figure 5A). Using ChIP-PCR, we could confirm
Ebf1 binding to two of these peaks (Figure 5B). Zfp521 levels rise
in 3T3-L1 cells after transduction of shEbf1 (Figure 5C), and are
elevated in Ebf1
2/2MEFs (Figure 5D). Furthermore, restoring
Ebf1 levels in these cells represses Zfp521 (Figure 5E). These data
indicate a role for Ebf1 as a negative regulator of Zfp521 gene
expression.
Discussion
Here we have identified Zfp521 as a potent repressor of
adipogenesis in vitro and in vivo. Zfp521 acts early in the cascade
of terminal adipocyte differentiation. Our group previously
showed that Ebf1 promotes adipogenesis by inducing the
expression of PPARc and C/EBPa [25] and a recent study
showed that Ebf1 is required for early commitment of the adipose
lineage [28]. Gupta et al. showed that Zfp423 acts as a
preadipocyte commitment factor [15]. Zfp521 acts upstream, to
inhibit the expression of Zfp423, and also inhibits the expression
and function of Ebf1 through physical interaction. As differenti-
ation proceeds, Ebf1 represses the expression of Zfp521 via direct
binding to an intronic enhancer (see Figure 5F for a model).
Therefore, our data suggest that Zfp521 participates in a feedback
loop during adipose commitment and differentiation.
Interestingly, although the anti-adipogenic effects of Zfp521
were demonstrated in every model we tested, these actions were
consistently most dramatic in C3H10T1/2 cells. C3H10T1/2 cells
Figure 3. Zfp521 suppresses Zfp423 expression. (A) 3T3-L1
preadipocytes were transduced with retrovirus expressing sh521, shScr,
Zfp521, or empty vector. After puromycin selection, RNA was collected
and submitted for analysis using Affymetrix arrays. The Venn diagram
shows the number of genes up-regulated by sh521 (sh521/shScr.1.5-
fold) and down-regulated by Zfp521 (Zfp521/pMSCV,0.7-fold). The
heat map corresponds to genes in the intersecting set. (B) Overexpres-
sion of Zfp521 in C3H10T1/2 cells represses Zfp423 expression by Q-
PCR. (C) Knockdown of Zfp521 in C3H10T1/2 cells enhances Zfp423
expression by Q-PCR. Data presented as mean 6 SD, n=3,*p,0.05.
doi:10.1371/journal.pbio.1001433.g003
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multi-lineage potential. This observation is consistent with reports
that Zfp521 promotes bone and cartilage development in vivo
[32]. In chondrocytes, Zfp521 acts downstream of parathyroid
hormone-related peptide (PTHrP) to inhibit Runx2 and increasing
cellular proliferation and subsequent growth plate thickness [32].
The published data on Zfp521 in bone development have been
less clear, with discordance seen between in vitro (where Zfp521
inhibits osteogenesis) and in vivo (where overexpression of Zfp521
increases bone mass) studies [33], and it has been proposed that
inhibition of Runx2 by Zfp521 may have differential effects on
bone development depending upon timing [33]. Our own data
support a role for Zfp521 as a pro-osteogenic factor in vitro
(Figures S2A–D). The actions of Zfp521 on osteogenesis and
adipogenesis place this factor among a group of transcription
factors recently discovered to regulate the relative abundance of
these two lineages. These factors, which include Rb, Maf, fosB,
Taz, and Ebf1 [10–13,33], have been the subjects of intense
inquiry given obvious links to two human diseases of great
importance, osteoporosis and obesity.
How does Zfp521 inhibit adipogenesis? Our data point strongly
to a mechanism involving the transcriptional repression of the
proadipogenic factor Zfp423, although other targets are certainly
possible. Relatively few genes were concordantly regulated by
knockdown and overexpression of Zfp521 in preadipocytes, and
most have no obvious link to adipocyte differentiation. An
Figure 4. Zfp521 inhibits Ebf1 transcriptional activity through physical interaction. (A) 3T3-L1 preadipocytes were harvested and
endogenous Ebf1 was immunoprecipitated using anti-Ebf1 beads and blotted with normal goat-IgG or anti-Zfp521. (B–D) 3T3-L1 preadipocytes were
co-transfected with vectors expressing Flag-Zfp521, Myc-Ebf1, and various reporter plasmids containing the mb1-promoter (B), Sncg-promoter (C), or
Cebpa-promoter (D). At 24 h after transfection, luciferase activity was normalized to b-galactosidase activity. Data presented as mean 6 SD, n=4,
*p,0.05. (E) 3T3-L1 preadipocytes were stably transduced with Flag-Ebf1 or Flag-Zfp521. ChIP assay was performed on 3T3-L1 cells that were treated
with DMI for 1 h using anti-Flag antibody or an IgG control using PCR primers directed at regions of the Cebpa containing the putative Ebf sites. (F, G)
Immortalized Zfp521
+/+ and Zfp521
2/2 MEFs were transduced with a retrovirus expressing Ebf1, Zfp521, or empty vector and differentiated prior to
staining with oil red-O after 8 d (F) and adipocyte gene expression was measured by Q-PCR (G). (H, I) C3H10T1/2 cells were transduced with a
retrovirus expressing Zfp521WT, Zfp521DZF27-30, Zfp521D13aa, or empty pMSCV vector. Cells were differentiated with DMIR and stained with oil
red-O and gene expression was measured on day 6. (J) Zfp521 and Ebf1 were expressed in C3H10T1/2 cells alone or in combination, and expression
of Zfp521, Ebf1, and Zfp423 was determined by Q-PCR. (K) Zfp521, Zfp521D27-30, or pMSCV was expressed in C3H10T1/2 cells and expression of
Zfp521, Ebf1, and Zfp423 was determined by Q-PCR. Data presented as mean 6 SD, n=3,*p,0.05.
doi:10.1371/journal.pbio.1001433.g004
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(MKP-1). However, MKP-1 has been shown to promote
adipogenesis [40], while we found it to be positively regulated
by Zfp521. Other target genes are likely to be involved, such as
Cebpa, which exhibit subthreshold levels of change on the
microarray. Zfp521 may have intrinsic DNA-binding activity
[22], and some actions may well be mediated by direct effects on
the expression of critical developmental genes, although this
remains to be proven. We show, however, that binding and
inhibition of Ebf1 is a major mechanism by which Zfp521 inhibits
adipogenesis. A mutant allele of Zfp521 that cannot bind Ebf1 has
greatly reduced ability to repress differentiation. We posited that a
simple competition could exist between Zfp423 and Zfp521 for
Ebf1, given the high degree of similarity in their C-terminal zinc
finger domains. In fact, this proved not to be the case, with Zfp521
and Zfp423 enhancing each others’ binding to Ebf1. Furthermore,
Zfp521 and Zfp423 can bind directly to one another, suggesting
that they form heterodimers that inhibit Ebf1 action. In this vein,
we propose that Ebf1 action is contingent upon the relative
amounts of Zfp521 and Zfp423 in the resulting complex, although
this needs to be formally tested. Finally, this could explain the
small amount of residual antiadipogenic activity seen with the
Zfp521DZF27-30 mutant, which may bind to Zfp423 despite
being unable to bind Ebf1. Zfp423 has Smad-binding properties,
which have been implicated in its proadipogenic effects [15], and
binding directly to Zfp521 could attenuate this activity. We have
not investigated whether additional antiadipogenic actions of
Zfp521 could be due to effects on the Smad pathway.
Our data thus add to our knowledge of early events in
mesenchymal differentiation, and may be an exploitable angle in
the battle to promote metabolic and skeletal health.
Materials and Methods
Cell Culture
3T3-L1 preadipocytes were obtained from ATCC and main-
tained in DMEM with 10% calf serum.
HeLa cells, 3T3-F442A cells, and MEFs were maintained in
DMEM with 10% FBS. C3H10T1/2 cells were grown and
differentiated in aMEM with 10% FBS. Primary Zfp521
+/+and
Zfp521
2/2 MEFs were generated and immortalized as described
previously [41]. For adipose differentiation, cells were induced
with a cocktail of dexamethasone (1 mM), insulin (5 mg/ml), and
isobutyl methylxanthine (0.5 mM) (DMI) beginning 2 d after
confluence was reached (day 0). For MEFs and C3H10T1/2 cells,
rosiglitazone (Rosi, 100 nM,5 mM) was added to the DMI
cocktail (DMIR). After 2 d, media was changed to DMEM/FBS
plus insulin (5 mg/ml) for an additional 2 d and thereafter
maintained until harvest in DMEM/FBS only. Human adipose
derived stromal cells (hASCs) were obtained from Jeff Gimble and
were maintained in MesenPro media (Invitrogen); cells were
differentiated as described previously [42]. Primary MEFs were
isolated on embryonic day 13.5 and differentiated with DMI plus
Rosi. For osteoblastogenesis, confluent cells were fed with a-MEM
media containing b-glycerophophate (2 mM) and ascorbic acid
(50 mg/ml) every other day.
Plasmids
Cebpa (2534/116) and Sncg (22647/21468) promoter
constructs were generated by ligating PCR amplicons into pGL4
basic (Promega). 6-myc Ebf1 and 36mb-1 reporter construct were
obtained from M. Sigvardsson [43]. 2HA-Zfp521-pCMV, 3Flag-
Zfp423-pBICEP, and 3Flag-Zfp521-pBICEP were subcloned at
the SalI/BamHI sites. Oligonucleotides representing specific
hairpin sequences forZfp521 or a scrambled control were ligated
into pSiren-RetroQ (Clontech) at the BamHI/EcoRI sites. To
construct WT-Zfp521-pMSCV and Zfp521DZF27-30-pMSCV,
wild-type or zinc finger 1,26 regions were PCR amplified with
primers containing flanking BamHI and SalI sites and subcloned
into pMSCV at the BglII and XhoI sites.
Retrovirus Preparation and Infection
Retroviral preparation and infection were performed as
previously described [44]. Briefly, pMSCV-based overexpression
constructs and pSIREN-based knockdown constructs were
cotransfected with gag-pol and VSV-G-expressing plasmids into
Phoenix packaging cells. 2 d after transfection, viral supernatant
was harvested, filtered through 0.45-mm filters, and added to target
cells for 12 h along with 8 mg/ml Polybrene. Cells were selected
with 4 m/ml puromycin or 400 mg/ml hygromycin until control
Figure 5. Ebf1 suppresses Zfp521 expression via an intronic
binding site. (A) ChIP-Seq tracks corresponding to the Zfp521 locus
are shown for three histone marks: H3K4me3 (green), H3K27Ac (black),
and H3K36me3 (blue) at four time-points during 3T3-L1 adipogenesis. A
cluster of Ebf1 peaks highlighted in the red box contains three putative
Ebf1-responsive elements (EBF-RE). (B) ChIP-PCR analysis was performed
with antibody against IgG or Ebf1 in 3T3-L1 preadipocytes. Immuno-
precipitated DNA was amplified with Q-PCR using primers designed for
the three putative EBF-REs shown in (A). (C) Zfp521 mRNA expression
was measured in 3T3-L1 preadipocytes transduced with shScr or shEbf1.
(D) Zfp521 mRNA expression was measured in confluent Ebf1
+/+ and
Ebf1
2/2 MEFs. (E) Ebf1 and Zfp521 mRNA expression was measured in
Ebf1
+/+ and Ebf1
2/2 MEFs transduced with Ebf1 or empty vector. Data
presented as mean 6 SD, n=3,*p,0.05. (F) A proposed model for the
transcriptional cascade involving Zfp521, Ebf1, and Zfp423.
doi:10.1371/journal.pbio.1001433.g005
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cassette were all killed.
RNA Extraction and Q-PCR
Total RNA was extracted from cells or tissues using TRIzol
reagent according to the manufacturer’s instructions. cDNA was
reverse-transcribed from 2 mg of RNA by using the RETROscript
first strand synthesis kit (Ambion). Q-PCR was performed with
SYBR Green QPCR Master Mix (Applied Biosystems) using a
7900HT Fast Real-Time PCR System (Applied Biosystems). The
relative amount of mRNA normalized to cyclophilin B was
calculated by using the delta-delta method [45].
Co-immunoprecipitation and ChIP-PCR Studies
Co-immunoprecipitation (Co-IP) was performed according to a
modified protocol as previously described [44]. Briefly, HeLa and
293T cells were transfected with various DNA constructs using
calcium phosphate or Lipofectamine (Invitrogen). A day after
transfection, cells were lysed with Triton X lysis buffer
(BostonBioProducts) containing 50 mM Tris-HCL, pH 7.4,
150 mM NaCl 1% Triton X-100, 5 mM EDTA, plus protease
inhibitors (Complete mini, Roche). 500 mg of protein was
incubated with the appropriate antibodies overnight. The next
day, protein A/G beads (Santa Cruz Biotechnology) were added
and incubated for 1 h, washed with lysis buffer five times and PBS
once. Beads were eluted with non-reducing SDS/PAGE loading
buffer and subjected to SDS/PAGE and Western blotting. For
ChIP-PCR, genomic DNA was extracted, and IP was performed
according to the manufacturer’s protocol (Upstate Biotechnology).
Cross-linking was performed as described in the manufacturer’s
protocol. DNA was sheared using a sonic dismembrator model
100 (Fisher Scientific) at half maximum speed for 10 s. IP was
performed using 2 mg of anti-Flag (Sigma), anti-Ebf1 (Abcam), or
IgG (Sigma).
Western Blot Analysis
Whole-cell protein lysates were prepared according to the
manufacturer’s protocol using Triton-X lysis buffer and protease
inhibitor cocktail. 20–30 mg of protein was resolved using 4%–
20% Tris-glycine gradient gels and transferred to PVDF
membrane. After blocking with 5% non-fat dried milk in PBS-
Tween (0.25%), membranes were incubated with the appropriate
primary antibodies against HA (Covance), FLAG (Sigma), FABP4,
MYC, C/EBPa (Santa Cruz Biotechnology), or ZFP521. Anti-
goat and anti-mouse or rabbit IgG–peroxidase conjugate (Sigma)
were used to detect primary antibodies.
Reporter Assays
Reporter plasmids were co-transfected with 6Myc-Ebf1, 3Flag-
Zfp521-pBICEP, WT-Zfp521-pMSCV, or Zfp521DZF27-30-
pMSCV to 3T3-L1 preadipocytes by using Lipofectamine 2000
or Amaxa nucleofactor (Lonza). Beta-galactosidase expression
vector (50 ng) was cotransfected to normalize transfection
efficiency. Statistics were performed using the Student’s t test.
Implantation of 3T3-F442A Cells
3T3-F442A cells were transduced with scrambled (Scr) or
shZfp521 expressing vectors. For transplantation, 10
7 shScr and
shZfp521 expressing cells were mixed together in 200 ml PBS and
subcutaneously implanted (2610
7cells per site) to the sternum of
10–14-wk-old male nude mice (Crl:NU/NU-nuBR, Taconic). An
aliquot of the mixed cell population was saved at 280uC for
quantification of input ratio. 10 wk after transplantation, fat pads
were carefully dissected, and either fixed in buffered formalin or
stored at 280uC for genomic DNA and protein isolation. For
quantification of the relative abundance of Scr versus shZfp521
cells from transplants, 50 ng of genomic DNA was used to amplify
scrambled-, shZfp521-specific, or common vector sequences (see
Table S1).
Animals
Zfp521
+/2 mice were obtained from Soren Warming. Animal
studies were performed in accordance with the Institutional
Animal Care and Use Committee (IACUC) of the Beth Israel
Deaconess Medical Center.
Assessment of Embryonic Development of Adipose
Tissue
Zfp521
+/2 male and female mice were mated on day 0 and
males were removed early day 1. On embryonic day 18.5,
pregnant females were euthanized and embryos were dissected.
Body weight, liver, and interscapular brown adipose tissue weight
of individual embryos was measured. Tails were saved for
genotyping and embryos were fixed with 4% paraformaldehyde.
The next day embryos were washed with PBS, stored in 70%
ethanol, and embedded in paraffin and sectioned for HE staining
and immunostaining with FABP4 antibody. For secondary
antibody, anti rabbit Alexa 647 (Invitrogen) was used along with
the FX enhancer (Invitrogen) and Prolong Gold Anti-Fade
Reagent with DAPI (Invitrogen) according to the manufacturers
instructions. The number of adipocytes was measured by counting
cells that were both lipid-filled and FABP4 positive. To detect
Zfp521 mRNA expression in Zfp423-marked preadipocytes,
epididymal fat tissue from Zfp423
GFP mice was fractionated and
sorted as described in [16].
Statistical Analyses
All results are presented as means standard deviations.
Statistical difference was determined using Student’s t test.
Supporting Information
Figure S1 (A, B) 3T3-L1 cells (A), 3T3-F442A cells (B),
and human ASCs (C) were differentiated and RNA
isolated at the indicated time points. Gene expression
ofZfp521/ZNF521 and Pparg/PPARG was measured by
Q-PCR. Relative expression was normalized to cyclophilin. Data
shown as mean of three biological replicates. (C, D) Retrovirally
transduced 3T3-L1 cells expressing Zfp521, empty vector,
shRNA specific forZfp521 (sh521) or a scrambled hairpin (Scr)
were differentiated with DM or DMI and stained with oil red-O
(D, F) and adipocyte markers were determined by Q-PCR (E, G)
on day 8. (H, I) Primary MEFs were generated from Zfp521
+/+
and Zfp521
2/2embryos and differentiated with DMIR stained
with oil red-O (H) and adipocyte markers were determined by
Q-PCR (I) on day 8. (J, K) Stromal vascular cells were isolated
from epididymal adipose tissue of Zfp521
+/+ and Zfp521
+/2 mice.
Cells were differentiated with DMIR, stained with oil red-O (J)
and adipocyte gene expression was determined by Q-PCR (K) on
day 8. Data presented as mean 6 SD, n=3, *p,0.05. (L, M)
Human ASCs were transfected with Zfp521 or pMSCV and
differentiated with DMIR. Adipogenesis was assessed with oil
red-O and gene expression analysis on day 7.
(TIF)
Figure S2 (A–D) Retrovirally transduced C3H10T1/2
cells (A, B) and primary MEFs (C, D) expressing Zfp521
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containing b-glycerophosphate and ascorbic acid. After 7
(10T1/2) or 18 (MEFs) d, cells were stained with alkaline
phosphatase or Alizarin Red and osteogenic markers were
measured by Q-PCR (Alpl, Alkaline phosphatase; Osx, osterix;
Ocn, Osteocalcin; Col1A1, Type I collagen; Bsp: Bone sialopro-
tein). (E, F) MEFs from (C, D) differentiated with DMIR stained
with oil red-O (E) and adipocyte markers were determined by Q-
PCR (F) on day 8.
(TIF)
Figure S3 (A) Adipocyte gene expression of BAT from
Zfp521
+/+and Zfp521
2/2 embryos were measured by Q-
PCR. Data presented as mean ± SD, n=4,*p,0.05. (B, C)
shZfp521andshScrexpressingF442Acellsweremixedandinjected
into nude mice. Resulting fat pads were dissected and subjected to
HE staining (B) and immunoblotting of C/EBP and FABP4 (n=4)
(C). (D) F442A cells expressing sh521 or shScr were mixed at the
indicated ratios and subjected to genomic DNA isolation. 50 ng of
genomic DNA was used as template for Q-PCR to detect variant
and invariant hairpins. Relative fold ratio was determined by
normalizing samples to the 1:1 mixture of cells 10 wk after
transplantation. (E, F) C3H10T1/2 cells were transduced with
pMSCV, PPARc, or C/EBPa in the presence or absence of Zfp521
as indicatedpriorto differentiation with DMIR andstaining withoil
red-O and adipocyte gene expression was measured by Q-PCR. (G)
Immortalized Pparg
+/2 and Pparg
2/2 MEFs were transduced with
retrovirusbearing shScr orshZfp521 and stainedwithoilred-O.(H,
J) Zfp521 mRNA was measured by Q-PCR prior to differentiation.
(I, K) Cells from (H and J) were differentiated with DMIR and
adipocyte genes were measured by Q-PCR. Data presented as
mean 6 SD, n=3,*p,0.05.
(TIF)
Figure S4 (A) 3T3-L1 preadipocytes were transduced
with retrovirus expressing sh521, shScr, Zfp521, or
empty vector. After puromycin selection, RNA was collected
and submitted for analysis using Affymetrix arrays. The Venn
diagram shows the number of genes down-regulated by sh521
(sh521/shScr,0.7-fold) and up-regulated by Zfp521 (Zfp521/
pMSCV.1.5-fold). The heat map corresponds to genes in the
intersecting set. (B) HeLa cells were transfected with HA-Zfp521,
Myc-Ebf1, or empty vector as indicated. After 24 h, cells were
harvested and immunoprecipitation was performed with anti-Myc
beads. 10% input and the SDS eluate were subjected to Western
blotting with antibodies against HA or Myc. WCL, whole cell
lysate. (C) Immortalized Zfp521
+/+ and Zfp521
2/2 MEFs were
transduced with a retrovirus expressing Flag-Ebf1; expression was
measured by western blotting with anti-Flag prior to differentia-
tion. (D) Schematic depicting the protein structure of WT Zfp521,
Zfp521DZF27-30, and Zfp521D13aa. Individual zinc fingers are
depicted as black bars. (E) 3T3-L1 preadipocytes were transfected
with Myc-Ebf1 and either Flag-Zfp521WT or Flag-Zfp521D27-
30. 24 h after transfection, cells were harvested and immunopre-
cipitation was performed using anti-Myc beads. 10% input and the
SDS eluate were subjected to Western blotting with antibodies
against Zfp521, Flag, or Myc. (F) 3T3-L1 preadipocytes were co-
transfected with vectors expressing Zfp521, Zfp521D27-30,
Zfp521D13aa, Myc-Ebf1, and Cebpa-promoter. 24 h after
transfection, luciferase activity was determined. Data presented
as mean 6 SD, n=6, *p,0.05. (G) C3H10T1/2 cells were
transduced with a retrovirus expressing Zfp521 WT,
Zfp521DZF27-30, Zfp521D13aa, or empty pMSCV vector.
Protein expression of Zfp521 was determined by immunoblotting.
(TIF)
Figure S5 (A–C) 293T cells were transiently transfected
with 2HA-Zfp521 (521), 3Flag-Zfp423 (423), and 6Myc-
Ebf1 (Ebf1). After 48-h transfection, cell lysates were subjected to
co-immunoprecipitation with a-Flag, a-HA, or a-Myc antibodies
as indicated and 5% input were blotted with a-Flag, a-HA, or a-
Myc antibodies.
(TIF)
Figure S6 Gene expression was measured by Q-PCR
before confluency (70%) and after adding DMIR in
C3H10T1/2 cells at indicated time points.
(TIF)
Table S1 Primer sequences.
(DOC)
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